MedRx Co., Ltd (TYO:4586)

Japan · Delayed Price · Currency is JPY

110.00

-15.00 (-12.00%)

Mar 6, 2026, 11:30 AM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development of Pharmaceutical Formulations and Ancillary Operations		257.00M	29.00M	59.00M	8.00M	115.00M
Development of Pharmaceutical Formulations and Ancillary Operations Growth		786.21%	-50.85%	637.50%	-93.04%	-31.95%
Total		257.00M	29.00M	59.00M	8.00M	115.00M
Total Growth		786.21%	-50.85%	637.50%	-93.04%	-31.95%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Japan		257.00M	29.00M	59.00M	8.00M	115.00M
Japan Growth		786.21%	-50.85%	637.50%	-93.04%	-31.95%
Total		257.00M	29.00M	59.00M	8.00M	115.00M
Total Growth		786.21%	-50.85%	637.50%	-93.04%	-31.95%

Source: S&P Global Market Intelligence.